Drug Delivery and Translational Research - Editorial Board Profiles
Editor-in-chief
María José Alonso
Research topics: formulation of proteins and RNA using nanotechnology, rational design of nanocarriers intended to overcome drug biological barriers.
María José Alonso is Professor of Biopharmaceutics and Pharmaceutical Technology at the University of Santiago de Compostela, Spain.
Laboratory website (this opens in a new tab) | Twitter (this opens in a new tab)
She was President of the Controlled Release Society (CRS) from 2017-19.
Editors for the Americas:
Mansoor Amiji, EditorResearch topics: synthesis of novel polymeric materials, microparticles and nanoparticles for medical and pharmaceutical applications, targeted drug delivery.
Mansoor Amiji is currently the University Distinguished Professor, Professor of Pharmaceutical Sciences and Professor of Chemical Engineering at Northeastern University in Boston, Massachusetts, USA. He is also the Director of the Laboratory of Biomaterials and Advanced Nano-Delivery Systems (BANDS).
Emmanuel Ho, Associate EditorResearch topics: development and characterization of innovative drug delivery strategies including nanomedicines, medical devices and biomaterials for the treatment and prevention of HIV/AIDS, cancer, and chronic wound healing.
Dr. Ho is an Associate Professor in the School of Pharmacy at the University of Waterloo, Canada.
Editors for Asia and Oceania:
Zhen Gu, Editor
Research topics: development of advanced drug delivery formulations, materials and devices, especially for the treatment of cancer and diabetes.
Dr. Gu is a Qiushi Distinguished Chair Professor and Dean in the College of Pharmaceutical Sciences at Zhejiang University, China.
Ouyang Defang, Associate EditorResearch topics: computational pharmaceutics, artificial intelligence of pharmaceutical formulations, Multi-scale modeling in drug delivery, pharmacoinformatics
Ouyang Defang is Assistant Professor at the University of Macau.
Editors for EU and Africa
Ryan Donnelly, EditorResearch topics: advanced polymeric drug delivery systems with a particular interest in transdermal and intradermal delivery.
Ryan Donnelly holds the Chair in Pharmaceutical Technology at Queen's University Belfast's (UK) School of Pharmacy and is Director of the research program Materials & Advanced Technologies for Healthcare (this opens in a new tab).
Fabiana Quaglia, Associate Editor
Research topics: Development of engineered polymeric nanoplatforms to overcome tumour resistance and inhalable nanotherapeutics for lung chronic diseases.
Fabiana Quaglia is Full Professor of Pharmaceutical Technology, Department of Pharmacy, at the University of Napoli FEDERICO II, Italy.
Focus Groups Editors
Editor:
Steven LittleResearch topics: Drug delivery
Dr. Steven Little is a William Kepler Whiteford Endowed Professor of Chemical and Petroleum Engineering, Bioengineering, Pharmaceutical Sciences, Immunology, Ophthalmology and The McGowan Institute for Regenerative Medicine at the University of Pittsburgh, USA.
He is Director-at-Large of the CRS.
Associate Editors:
Olivia Merkel
Research topics: nucleic acid formulation and delivery via pulmonary and nasal administration routes
Olivia Merkel has been a Professor of Drug Delivery at LMU Munich since 2015. She was the president of the German CRS Chapter from 2020-2021 and has been the Chair of the Transdermal and Mucosal Delivery Focus Group since 2020.
Laboratory (this opens in a new tab) | Twitter (this opens in a new tab)
James Moon
Research topics: immunotherapy against cancer and autoimmune diseases, gut microbiome.
Dr. Moon is Professor in the Department of Pharmaceutical Sciences at the University of Michigan, Ann Arbor, USA. He has previously served as the chair of Immuno Delivery Focus Group in CRS.
Laboratory (this opens in a new tab)
Gaurav Sahay
Hélder Santos
Research topics: nanoparticles/nanomedicines, biomaterials for tissue engineering applications, industrial scale-up validation, batch-to-batch reproducibility, and controllability of the biomaterials’ physicochemical properties for translation into the clinic.
Prof. Santos is a Full Professor in the Department of Biomedical Engineering and Head of the Department of Biomedical Engineering at the University of Groningen/ University Medical Center Groningen, and Research Director of the Nanomedicines and Biomedical Engineering Lab, Faculty of Pharmacy, at the University of Helsinki.
He was the Chair of Controlled Release Society Focus Group in Nanomedicine and Nanoscale Delivery
Laboratory (this opens in a new tab) | Twitter (this opens in a new tab) | LinkedIn (this opens in a new tab)
Thakur Singh
Research topics: Long-acting implants for delivery of biologics and small molecules, biologic formulations, microneedles, electrospinning, synthesis of peptides/polymers and medical devices for precision drug delivery.
Raj Thakur is Professor in Pharmaceutics and Drug Delivery, School of Pharmacy, Queens University Belfast, UK. He is Founder and CTO of Re-Vana Therapeutics (this opens in a new tab), Belfast, UK.
Twitter (this opens in a new tab)
Inspirational Notes Editors
Richard Korsmeyer
Research topics: Drug delivery and pharmaceutical development.
Richard Korsmeyer is an independent consultant who has been involved with drug delivery technology for over 30 years, during which time his work has ranged from basic research to development of commercial products.
He has served on the board of directors of the CRS as Director-at-Large.
Twan Lammers
Research topics: Nanomedicine formulations in cancer.
Twan Lammers is professor at the faculty of medicine at RWTH Aachen University, Germany.
He is Director-at-Large of the CRS.
Andy LewisResearch topics: Translational drug delivery research
Andy Lewis is VP Pharmaceutical Sciences at Quotient Sciences, UK.
He has served on the board of directors of the CRS as both Director-at-Large and Secretary.
Mark Prausnitz
Research topics: Transdermal and transmucosal drug delivery technologies.
Mark Prausnitz is Regents’ Professor and J. Erskine Love, Jr. Chair of Chemical and Biomolecular Engineering at the Georgia Institute of Technology, USA.
He has served on the board of directors of the CRS as Director-at-Large.
Daniel SiegwartResearch topics: delivery of siRNA, miRNA, mRNA, and CRISPR/Cas therapeutics to manipulate gene expression in tumors and to correct genetic diseases; stimuli-responsive cancer imaging probes.
Dr. Siegwart is an Associate Professor in the Department of Biochemistry and the Simmons Comprehensive Cancer Center at the University of Texas Southwestern Medical Center, USA.
Cornell Stamoran
Research topics: Delivery technologies for drugs, biologics, and consumer health products.
Cornell Stamoran serves as Vice President of Strategy and Government Affairs for Catalent Pharma Solutions,, USA, and is a founder and Co-Chair of Catalent’s Applied Drug Delivery Institute.
Cornell Stamoran is Treasurer of the CRS.
Local Chapters Editor
Avi Schroeder
Research topics: Targeted technology, drug delivery and theranostics, agricultural nanotechnology.
Avi Schroeder is Professor of Chemical Engineering at the Technion – Israel Institute of Technology where he heads the Laboratory for Targeted Drug Delivery and Personalized Medicine Technologies.
Laboratory website (this opens in a new tab)
Avi Schroeder is chair of the International Committee of the CRS.
Special Issues Editors
David Putnam
Research topics: Functional materials and drug delivery, osteoarthritis and infectious disease
David Putnam is Professor at the Meinig School of Biomedical Engineering and the Smith School of Chemical and Biomolecular Engineering, Cornell University, USA.
Laboratory website (this opens in a new tab)
He was treasurer of the CRS from 2017-19.
Ilva Rupenthal
Research topics: Ocular drug delivery.
Ilva Rupenthal is an Associate Professor and Director of the Buchanan Ocular Therapeutics Unit (this opens in a new tab), Department of Ophthalmology, University of Auckland, New Zealand.
She has previously served as Director-at-Large and currently is the Secretary of the CRS.
Bruno SarmentoResearch topics: development of functionalized nanomedicines and their application in the pharmaceutical and biomedical fields.
Dr. Sarmento is Principal Investigator at INEB/i3S, Institute of Biomedical Engineering/Institute for Investigation and Innovation in Health, University of Porto, and Assistant Professor at IUCS, Instituto Universitário de Ciências da Saúde, Portugal.
Laboratory webpage (this opens in a new tab) | e-mail (this opens in a new tab) | Twitter (this opens in a new tab)
Reviews Editors
Laura Ensign
Research topics: Mucosal drug delivery, ocular drug delivery, drug-eluting devices for surgical applications.
Dr. Ensign is an Associate Professor of Ophthalmology and the Vice Chair for Research for the Wilmer Eye Institute at the Johns Hopkins University School of Medicine.
She previously served at the Secretary of the Transdermal and Mucosal Drug Delivery Focus Group and served at the Director of Invited Speakers for the CRS 2021 Annual Meeting.
Twitter (this opens in a new tab) | Laboratory website (this opens in a new tab)
Yu-Kyoung OhResearch topics: delivery of chemical and biological drugs using versatile nanobiomaterials.
Yu-Kyoung Oh is a professor at the College of Pharmacy, Seoul National University (Republic of Korea) and a fellow of the Korean Academy of Science and Technology.
Yu-Kyoung Oh is Director-at-Large of the CRS.
Steve Schwendeman
Research topics: Encapsulation, stabilization, and controlled release of bioactive agents.
Steven P. Schwendeman is the Ara G. Paul Professor and Chair of Pharmaceutical Sciences and Professor of Biomedical Engineering at the University of Michigan Biointerfaces Institute (BI), USA.
Steven P. Schwendeman has served a chair of the College of Fellows of the CRS.
Ankur SinghResearch topics: engineering of biomaterials-based platforms for cell and immune modulation, cell-biomaterial interactions, cell adhesion, stem cell engineering, and vaccines.
Ankur Singh is an Associate Professor at the George W. Woodruff School of Mechanical Engineering at the Georgia Institute of Technology, USA.
e-Media Editor
Jung Soo Suk
Research topics: Development of nanoparticle-based drug and nucleic acid delivery systems.
Jung Soo Suk is an Assistant Professor of Ophthalmology and Chemical and Biomolecular Engineering at Johns Hopkins University, USA.
Gender, Diversity, and Inclusion Associate Editor
Morgan FedorchakResearch topics: drug delivery to the eye, development of novel biomaterials for ophthalmic applications.
Dr. Fedorchak is an Assistant Professor of Ophthalmology, Chemical Engineering, and Clinical & Translational Sciences at the University of Pittsburgh, USA. She is also the Director of the Ophthalmic Biomaterials Laboratory at Pitt and is affiliated with the Louis J. Fox Center for Vision Restoration.
Young Associate Editors
Hagar LaboutaResearch topics: Developing nanoparticles for crossing biological barriers for applications in maternal and fetal health, and tumour targeting.
Hagar Labouta is an Assistant Professor at the College of Pharmacy, University of Manitoba, Canada.
Hagar Labouta is a representative of the Young Scientists Committee of the CRS.
Tushar Kumeria
Research topics: Porous materials-based systems for theranostics and tissue engineering.
Dr. Tushar Kumeria is Scientia Senior Lecturer and an Australian National Health and Medical Research Council (NHMRC) Early Career Fellow (ECF) at the School of Materials Science and Engineering, The University of New South Wales (UNSW), Sydney, Australia.
Advisors
Robert LangerResearch topics: study and development of polymers to deliver drugs, particularly genetically engineered proteins, DNA and RNAi
Robert Langer is the David H. Koch Institute Professor at Massachussetts Institute of Technology.
Laboratory website (this opens in a new tab)
Nicholas PeppasResearch topics: advanced biomaterials, drug delivery and nanomedicine
Nicholas Peppas serves as the Cockrell Family Regents Chaired Professor in the Departments of Chemical, Biomedical Engineering, Pediatrics, Surgery and Molecular Pharmaceutics and Drug Delivery, and Director of the Institute of Biomaterials, Drug Delivery and Regenerative Medicine of the University of Texas at Austin.